TEPPER ROBERT I

CIK 000119259525 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001192595

Recent Transactions

50 trades

Award
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2020-06-26+13,550→ 13,550 total
Award
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2020-06-26+15,700→ 15,700 total
Disposition to Issuer
Neon Therapeutics, Inc.
Stock Option (Right to Buy)
2020-05-06−18,500→ 0 total
Disposition to Issuer
Neon Therapeutics, Inc.
Stock Option (Right to Buy)
2020-05-06−14,000→ 0 total
Disposition to Issuer
Neon Therapeutics, Inc.
Common Stock
2020-05-06−9,741,636→ 0 total
Award
Neon Therapeutics, Inc.
Common Stock
2019-06-25+18,500→ 18,500 total
Award
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2019-06-12+15,700→ 15,700 total
Award
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy)
2019-06-06+13,171→ 13,171 total
Award
Allena Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2019-06-05+14,000→ 14,000 total
Exercise of In-Money
CONSTELLATION PHARMACEUTICALS INC
Common Stock
2018-08-22$1.55/sh+51,032→ 3,034,083 total
Exercise of In-Money
CONSTELLATION PHARMACEUTICALS INC
Warrant (right to buy)
2018-08-22−51,032→ 0 total
Conversion
CONSTELLATION PHARMACEUTICALS INC
Series E Preferred Stock
2018-07-23−2,285,640→ 0 total
Conversion
CONSTELLATION PHARMACEUTICALS INC
Series D Preferred Stock
2018-07-23−1,086,411→ 0 total
Conversion
CONSTELLATION PHARMACEUTICALS INC
Series B Preferred Stock
2018-07-23−10,650,000→ 0 total
Purchase
CONSTELLATION PHARMACEUTICALS INC
Common Stock
2018-07-23$15.00/sh+266,667→ 2,983,051 total
Conversion
CONSTELLATION PHARMACEUTICALS INC
Series E-1 Preferred Stock
2018-07-23−3,107,930→ 0 total
Conversion
CONSTELLATION PHARMACEUTICALS INC
Series A Preferred Stock
2018-07-23−11,000,000→ 0 total
Conversion
CONSTELLATION PHARMACEUTICALS INC
Series F Preferred Stock
2018-07-23−1,000,000→ 0 total
Conversion
CONSTELLATION PHARMACEUTICALS INC
Common Stock
2018-07-23+2,705,334→ 2,716,384 total
Conversion
Neon Therapeutics, Inc.
Common Stock
2018-06-29+0→ 0 total
Conversion
Neon Therapeutics, Inc.
Common Stock
2018-06-29+0→ 0 total
Conversion
Neon Therapeutics, Inc.
Series B Preferred Stock
2018-06-29−0→ 0 total
Conversion
Neon Therapeutics, Inc.
Series A Preferred Stock
2018-06-29−0→ 0 total
Award
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2018-06-19+13,550→ 13,550 total
Award
Allena Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2018-06-08+10,182→ 10,182 total
Conversion
Allena Pharmaceuticals, Inc.
Common Stock
2017-11-06+2,575,964→ 2,575,964 total
Conversion
Allena Pharmaceuticals, Inc.
Series A Preferred Stock
2017-11-06−6,122,448→ 0 total
Conversion
Allena Pharmaceuticals, Inc.
Series B Preferred Stock
2017-11-06−4,629,630→ 0 total
Purchase
Allena Pharmaceuticals, Inc.
Common Stock
2017-11-06$14.00/sh+215,000→ 2,790,964 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2017-10-04$24.34/sh−24,777→ 29,516 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2017-09-19$18.00/sh−20,000→ 54,293 total
Conversion
KALA BIO, Inc.$KALA
Series Seed Preferred Stock
2017-07-25−3,677,374→ 0 total
Conversion
KALA BIO, Inc.$KALA
Common Stock
2017-07-25+1,621,092→ 1,621,092 total
Conversion
KALA BIO, Inc.$KALA
Common Stock Warrant (right to buy)
2017-07-25+33,333→ 33,333 total
Conversion
KALA BIO, Inc.$KALA
Series B Preferred Stock Warrant (right to buy)
2017-07-25−173,611→ 0 total
Conversion
KALA BIO, Inc.$KALA
Series B Preferred Stock
2017-07-25−2,265,764→ 0 total
Conversion
KALA BIO, Inc.$KALA
Series A Preferred Stock
2017-07-25−2,500,000→ 0 total
Award
KALA BIO, Inc.$KALA
Stock Option (right to buy)
2017-07-19+12,960→ 12,960 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2017-06-29$16.00/sh−15,000→ 44,777 total
Sale
Global Blood Therapeutics, Inc.
Common Stock
2017-04-06$33.23/sh−31,225→ 229,773 total
Conversion
Jounce Therapeutics, Inc.
Series A Preferred Stock
2017-02-01−35,750,000→ 0 total
Conversion
Jounce Therapeutics, Inc.
Series A Preferred Stock
2017-02-01−11,250,000→ 0 total
Conversion
Jounce Therapeutics, Inc.
Common Stock
2017-02-01+9,688,344→ 10,230,349 total
Conversion
Jounce Therapeutics, Inc.
Common Stock
2017-02-01+3,048,780→ 3,048,780 total
Other
bluebird bio, Inc.
Common Stock
2015-02-03+62,479→ 89,017 total
Other
bluebird bio, Inc.
Common Stock
2015-02-03−1,215,054→ 0 total
Other
bluebird bio, Inc.
Common Stock
2015-02-03+300,863→ 300,863 total
Other
bluebird bio, Inc.
Common Stock
2015-02-03−300,863→ 0 total
Sale
bluebird bio, Inc.
Common Stock
2014-09-12$36.59/sh−38,000→ 1,215,054 total
Other
bluebird bio, Inc.
Common Stock
2014-09-11−79,062→ 0 total

Companies

Recent Filings

Address

C/O THIRD ROCK VENTURES, LLC 29 NEWBURY STREET, 3RD FLOOR

BOSTON, MA, 02116

View on SEC.gov